Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
10,430 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A global CEO survey shows a shift away from junior roles as companies deploy AI. The move, echoed by Harvard findings...
Investing in critical metals blends opportunity with policy risk. This guide breaks down how to evaluate this critica...
AI agents are accelerating a pivot away from traditional apps toward private, verified software built by users themse...
As CME Group and ICE push 24/7 crypto trading, a heated clash with an offshore venue shines a spotlight on who contro...
Lawmakers and regulators weigh a $1.7 billion compensation fund to settle Trump’s suit with $1.7 against the IRS, a m...
A 2026 market shift is pushing workers away from chasing dozens of side gigs toward a lean, skill-driven playbook. Th...
Bitcoin remains stuck below its long-running 200-day moving average, trading near $58,000 as of mid‑May 2026. A decis...
U.S. stocks extended a multi-day rally as bullish options flow and leveraged ETF buying push prices higher. Analysts ...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
A big hedge fund dumped its entire ServisFirst stake, triggering questions about risk and valuation in regional banks...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...